© Copyright - Newspaper WordPress Theme by TagDiv
Timolol
Also known as / Synonyms: Timolol Maleate, Non-Selective Beta-Blocker
Beta-blocker eye drops that reduce aqueous humor production to lower elevated eye pressure in glaucoma.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
- Oral formulations: treatment of systemic hypertension, long-term prophylaxis after myocardial infarction, and migraine prophylaxis.
Contraindications (Do Not Use If…)
- Bronchial asthma or history of severe chronic obstructive pulmonary disease (COPD).
- Sinus bradycardia (heart rate < 50-60 bpm).
- Second or third-degree atrioventricular (AV) block.
- Overt cardiac failure or cardiogenic shock.
- Known hypersensitivity to timolol maleate.
Important Clinical Precautions & Warnings
- Systemic absorption from eye drops: topical ophthalmic beta-blockers undergo systemic absorption via nasolacrimal drainage, producing systemic cardiovascular and pulmonary beta-blockade; perform nasolacrimal occlusion (press inner corner of eye for 2 minutes after instillation).
- Severe bronchospasm in asthma: can cause fatal status asthmaticus even from eye drops; strictly contraindicated in asthmatic patients.
- Cardiac failure and bradycardia: monitor pulse and blood pressure; discontinue at first sign of cardiac decompensation.
- Hypoglycemia masking: can mask early warning signs of acute hypoglycemia (tachycardia, palpitations) in diabetic patients.
- Choroidal detachment: reported after filtration procedures with administration of aqueous suppressant therapy.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Safety and efficacy have been demonstrated in pediatric patients, but monitor closely for apnea and bradycardia. Geriatric: No overall differences in efficacy; elderly patients are more prone to systemic cardiovascular side effects.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Transient eye burning, stinging, itching, blurred vision, conjunctival hyperemia, foreign body sensation, headache, and mild bradycardia.
Serious Side Effects — Seek Urgent Medical Care
Severe bronchospasm and fatal status asthmaticus, severe bradycardia, heart block, heart failure decompensation, syncope, and anaphylaxis.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- Systemic beta-blockers: additive effects on systemic beta-blockade, heart rate, and intraocular pressure; monitor patients taking both.
- Calcium channel blockers (verapamil, diltiazem): heightened risk of bradycardia, hypotension, and AV conduction block.
- Digitalis glycosides: co-administration increases AV conduction delay and bradycardia risk.
- CYP2D6 inhibitors (quinidine, fluoxetine): inhibit timolol metabolism, significantly increasing systemic timolol levels and systemic beta-blocker side effects.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Use with caution — see notesTimolol passes into the systemic circulation and crosses the placenta. Topical use during pregnancy should be considered only if the potential benefit justifies potential fetal risk. If used near term, monitor neonate for bradycardia and hypoglycemia.
Lactation & Breastfeeding:
Timolol is excreted in human breast milk. With topical ophthalmic drops, systemic maternal levels are minimal, and infant exposure is clinically negligible when nasolacrimal occlusion is performed. Considered compatible with breastfeeding.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store eye drops at 15°C to 25°C (59°F to 77°F). Protect from light. Keep bottle tightly closed. Discontinue 4 weeks after opening.
⏱️ Missed Dose Protocol:
Instill the missed eye drop as soon as remembered. If close to the next scheduled dose, skip and resume regular routine. Do not instill two drops at the same time.
Systemic overdose from ingestion or excessive instillation produces severe bradycardia, hypotension, bronchospasm, and acute cardiac failure. Administer IV atropine for bradycardia, IV glucagon or dobutamine for cardiac failure, and inhaled beta-2 agonists for bronchospasm.
